Clinical Trials Logo

Mild Cognitive Impairment clinical trials

View clinical trials related to Mild Cognitive Impairment.

Filter by:

NCT ID: NCT04733989 Completed - Alzheimer Disease Clinical Trials

A Biomarker Database to Investigate Blood-Based and Digital Biomarkers in Participants Screened for Alzheimer's Disease (Bio-Hermes)

Start date: April 21, 2021
Phase:
Study type: Observational

The purpose of this study (Bio-Hermes) is to develop a blood, digital, and brain amyloid PET scan biomarker database that can be used to determine whether a meaningful relationship exists between digital tests, blood amyloid-beta, p-tau, and neurofilament biomarker levels and amyloid-beta levels identified through brain amyloid PET images. Blood collected will also be genetically sequenced to gain insights about genes and brain amyloid. The Bio-Hermes study will include 1,000 volunteers over the age of 60 screened for Preclinical Alzheimer's Disease, Prodromal AD, or Mild Dementia AD, and includes an endpoint enrollment requirement of 200 participants from underrepresented minority populations.

NCT ID: NCT04730635 Completed - Clinical trials for Mild Cognitive Impairment

Cognition Platform Study in Participants at Risk for Alzheimer's Disease (AD) (MK-0000-413)

Start date: March 23, 2021
Phase: Phase 1
Study type: Interventional

The main purpose of this study is to assess the ability of a repeated high-frequency site-based computerized cognitive assessment to evaluate the potential treatment effects of donepezil (MK-0000) compared with placebo among participants with mild cognitive impairment (MCI) or mild Alzheimer's Disease (AD). The primary study hypothesis is that the average percentage of correct responses on one card learning (OCL) task will be ≥2 percentage points in participants receiving donepezil compared with participants receiving placebo.

NCT ID: NCT04723667 Completed - Clinical trials for Mild Cognitive Impairment

Effects of an Empowerment-based Psycho-behavioral Program on Persons With Mild Cognitive Impairment

Start date: September 1, 2020
Phase: N/A
Study type: Interventional

This study aims to evaluate the effects of a 13-week empowerment-based psycho-behavioral program to improve neuropsychiatric symptoms, cognitive functions, and health-related quality of life among persons with mild cognitive impairment. Its feasibility will be first evaluated in a pilot study and subsequently in a randomized controlled trial (RCT)

NCT ID: NCT04721093 Completed - Clinical trials for Mild Cognitive Impairment

Effects of Photobiomodulation on Changes in Cognitive Function and rCBF in MCI

Start date: December 12, 2019
Phase: N/A
Study type: Interventional

This pilot study has two goals. The first is to see if the cognitive improves when VA and CA are stimulated in MCI patients, and the second is to do an explanatory data analysis to see if that improves cognitive in relation to the rCBF improvement.

NCT ID: NCT04717479 Completed - Clinical trials for Mild Cognitive Impairment

A Scalable Model for Promoting Functioning and Well-Being Among Older Adults With Mild Cognitive Impairment Via Meaningful Social Interactions: Project SPEAK!

Start date: March 19, 2021
Phase: N/A
Study type: Interventional

The goal of this study is to refine and test a strategy for engaging older adults with symptoms of SCD/MCI (subjective cognitive decline/mild cognitive impairment) as volunteers to help English language learners (ELLs) who live in the US improve their speaking skills via structured conversations using videoconferencing.

NCT ID: NCT04683835 Completed - Clinical trials for Mild Cognitive Impairment

Evaluation of Cognitive State in Senior Subjects Using Neurosteer EEG System

Start date: October 15, 2020
Phase:
Study type: Observational

This is an observational study. Patients who fulfill all inclusion criteria and none of the exclusion criteria will be enrolled in the study, be neurologically evaluated and will go through EEG recordings while listening to an auditory cognitive assessment tool. EEG recordings will be analyzed using proprietary computational analyses.

NCT ID: NCT04663256 Completed - Clinical trials for Mild Cognitive Impairment

Effects of Cognitive Stimulation in Older People With Mild Cognitive Impairment

Start date: January 11, 2021
Phase: N/A
Study type: Interventional

Mild cognitive impairment is becoming one of the most common cynical manifestations that affect older people. That is why there is a need to investigate non-pharmacological interventions that help to improve or maintain this problem.

NCT ID: NCT04648735 Completed - Clinical trials for Mild Cognitive Impairment

Driving Evaluation and Fitness for Persons With Cognitive Impairments

Start date: August 1, 2015
Phase: N/A
Study type: Interventional

Driving is an important activity for older adults because it frequently relates to personal independence and wellbeing. This study compared the driving behaviors of older drivers with normal cognition and with MCI in unfamiliar driving situations and difficult maneuvers, and explored the practice effect on driving performance of drivers with MCI. This study used an observational, cross-section research design.

NCT ID: NCT04647032 Completed - Clinical trials for Mild Cognitive Impairment

Enhancing Cognitive Control in Mild Cognitive Impairment Via Non-invasive Brain Stimulation

Start date: January 11, 2021
Phase: N/A
Study type: Interventional

The overall goal of this project is to improve cognitive control abilities in adults with mild cognitive impairment (MCI) through a form of non-invasive brain stimulation, transcranial alternating current stimulation (tACS).

NCT ID: NCT04646499 Completed - Clinical trials for Mild Cognitive Impairment

Feasibility of Gamma Transcranial Alternating Current Stimulation to Reduce Beta-amyloid Load and Improve Memory

Start date: January 18, 2021
Phase: N/A
Study type: Interventional

This project assessed the feasibility of transcranial alternating current stimulation in the gamma band to lower beta-amyloid load and improve memory performance.